These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
|
[X]
|
||||
|
Filed by a Party other than the Registrant
|
[ ]
|
||||
|
Check the appropriate box:
|
|||||
|
[ ]
|
Preliminary Proxy Statement
|
[ ]
|
Confidential, for Use of the
|
||
|
[X]
|
Definitive Proxy Statement
|
Commission Only (as Permitted
|
|||
|
[ ]
|
Definitive Additional Materials
|
by Rule 14a-6(e)(2))
|
|||
|
[ ]
|
Soliciting Material pursuant to
|
||||
|
Rule 14a-11(c) or Rule 14a-12
|
|||||
|
[X]
|
No fee required.
|
|
|
[ ]
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
Total fee paid:
|
|
|
[ ]
|
Fee paid previously with preliminary materials:
|
|
|
[ ]
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
|
Sincerely,
|
|
|
|
|
Peter Holst
President and Chief Executive Officer
|
|
1.
|
To elect five members of our Board of Directors to serve until our next Annual Meeting of Stockholders, or until their respective successors are duly elected and qualified;
|
|
|
2.
|
To conduct an advisory vote to approve the compensation paid to our named executive officers;
|
|
|
3.
|
To conduct an advisory vote to indicate how frequently stockholders believe we should conduct an advisory vote on the compensation of our named executive officers;
|
|
|
4.
|
To ratify the appointment of EisnerAmper LLP as our Independent Registered Public Accounting Firm for fiscal year 2013; and
|
|
|
5.
|
To transact other business as may properly come before the Annual Meeting.
|
|
By order of the Board of Directors,
|
|
|
|
|
Steven Peri
Corporate Secretary
|
|
|
·
|
each person (or group within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934) known by us to own beneficially more than 5% of the common stock;
|
|
|
·
|
the executive officers named in the Summary Compensation Table on page 10;
|
|
|
·
|
each of our directors and director nominees; and
|
|
|
·
|
all of our directors and executive officers as a group.
|
|
Name And Address of Beneficial Owners
(1)
|
Number of
Shares Owned
(2)
|
Percentage of
Outstanding
Shares
|
||||||
|
Executive Officers and Directors:
|
||||||||
|
Peter Holst
|
791,305 | 2.8 | % | |||||
|
Kenneth Archer
|
33,333 | (3) | * | |||||
|
Grant Dawson
|
39,583 | (3) | * | |||||
|
Jon A. DeLuca
|
47,186 | (3) | * | |||||
|
James S. Lusk
|
70,208 | (4) | * | |||||
|
Joseph Laezza
|
219,578 | * | ||||||
|
Tolga Sakman
|
— | * | ||||||
|
Steven Peri
|
155,000 | * | ||||||
|
All directors and executive officers as a group (10 people)
|
1,596,194 | 5.6 | % | |||||
|
5% Owners:
|
||||||||
|
Vicis Capital, LLC
445 Park Avenue, New York, NY 10022
|
8,942,805 | (5) | 31.2 | % | ||||
|
Jason T. Adelman
Cipher Capital Partners LLC, c/o Rothschild
1251 Avenue of the Americas, Suite 936, New York, NY 10020
|
2,096,575 | (6) | 7.3 | % | ||||
|
(1)
|
Unless otherwise noted, the address of each person listed is c/o Glowpoint, Inc., 430 Mountain Avenue, Murray Hill, NJ 07974.
|
|
(2)
|
Unless otherwise indicated by footnote, the named persons have sole voting and investment power with respect to the shares of common stock beneficially owned.
|
|
(3)
|
Includes 20,833 shares subject to stock options presently exercisable or exercisable within 60 days.
|
|
(4)
|
Includes 31,458 shares subject to stock options presently exercisable or exercisable within 60 days.
|
|
(5)
|
Based on ownership information from the Form 4 filed by Vicis Capital LLC on April 18, 2013, stating that the holder then owned 8,942,805 shares of the Company's common stock.
|
|
(6)
|
Based on ownership information from the Schedule 13G/A filed by Jason T. Adelman February 15, 2013, stating that as of December 31, 2012, holder then owned 2,096,575 shares.
|
|
Name
|
Age
|
Position with Company
|
||
|
Kenneth Archer
(1)(2)(3)
|
55 |
Director
|
||
|
Grant Dawson
(1)(2)(3)
|
44 |
Director, Chairman of the Compensation Committee
|
||
|
Jon A. DeLuca
|
41 |
Director, Chairman of the Board of Directors
|
||
|
Peter Holst
|
44 |
Director, Chief Executive Officer and President
|
||
|
James S. Lusk
(1)(2)(3)
|
57 |
Director, Chairman of the Audit Committee
|
|
(1)
|
Member of the Audit Committee
|
|
(2)
|
Member of the Compensation Committee
|
|
(3)
|
Member of the Nominating Committee
|
|
●
|
annually reviewing and making recommendations to the Board with respect to compensation of directors, executive officers and key employees of the Company;
|
|
●
|
annually reviewing and approving corporate goals and objectives relevant to Chief Executive Officer compensation, evaluating the Chief Executive Officer’s performance in light of those goals and objectives, and recommending to the Board the Chief Executive Officer’s compensation levels based on this evaluation;
|
|
●
|
reviewing competitive practices and trends to determine the adequacy of the executive compensation program;
|
|
●
|
approving and overseeing compensation programs for executive officers involving the use of the Company’s stock;
|
|
●
|
approving and administering cash incentives for executives, including oversight of achievement of performance objectives, and funding for executive incentive plans;
|
|
●
|
annually performing a self-evaluation on the performance of the compensation committee; and
|
|
●
|
making regular reports to the Board concerning the activities of the compensation committee.
|
|
●
|
a statement that the writer is our stockholder and is proposing a candidate for our Board of Directors for consideration by the nominating committee;
|
|
|
●
|
the name of and contact information for the candidate;
|
|
|
●
|
a statement of the candidate’s business and educational experience;
|
|
|
●
|
information regarding each of the factors set forth in the nominating committee charter sufficient to enable the nominating committee to evaluate the candidate;
|
|
|
●
|
a statement detailing any relationship between the candidate and any of our customers, suppliers or competitors;
|
|
|
●
|
detailed information about any relationship or understanding between the proposing stockholder and the candidate; and
|
|
|
●
|
a statement that the candidate is willing to be considered and willing to serve as our director if nominated and elected.
|
|
Name
|
Age
|
Position
|
||
|
David Clark
|
44 |
Chief Financial Officer
|
||
|
Steven Peri
|
64 |
Executive Vice President,
General Counsel and Secretary
|
|
Name and
Principal Position
|
Year
|
Salary
|
Bonus
|
Stock
Awards
(3)
|
Option
Awards
(5)
|
All Other
Compensation
|
Total
|
||||||||||||||||||
|
Joseph Laezza
Former Chief Executive Officer and President
(1)
|
2012 | $ | 356,362 | — | $ | 755,000 | $ | 1,183,630 | $ | 7,800 | $ | 2,302,792 | |||||||||||||
|
2011
|
$ | 275,000 | $ | 66,000 | — | — | $ | 6,600 | $ | 347,600 | |||||||||||||||
|
Steven Peri
General Counsel
(4)
|
2012
|
$ | 81,570 | $ | 16,667 | $ | 313,500 | $ | 151,032 | — | $ | 562,769 | |||||||||||||
|
2011
|
— | — | — | — | — | — | |||||||||||||||||||
|
Tolga Sakman
Former Chief Financial Officer
(2)
|
2012
|
$ | 212,016 | — | $ | 259,000 | $ | 177,544 | — | $ | 648,560 | ||||||||||||||
|
2011
|
$ | 81,186 | $ | 35,300 | $ | 105,000 | — | — | $ | 221,486 | |||||||||||||||
|
(1)
|
Mr. Laezza resigned from his position as the Company’s Chief Executive Officer on January 11, 2013. Mr. Peter Holst was appointed as Mr. Laezza’s successor following Mr. Laezza’s resignation.
|
|
(2)
|
Mr. Sakman resigned from his position on March 22, 2013. Mr. David Clark was appointed as Mr. Sakman’s successor immediately following Mr. Sakman’s resignation.
|
|
(3)
|
These amounts represent the aggregate grant date fair value for stock awards for fiscal years 2012 and 2011, respectively, computed in accordance with FASB ASC Topic 718. Please see Note 2 of the Notes to Consolidated Financial Statements contained in our 2012 Annual Report on Form 10-K for an explanation of the assumptions made in valuing these awards.
|
|
(4)
|
Mr. Peri joined the Company as its Executive Vice President, General Counsel and Secretary in September 2012.
|
|
(5)
|
These amounts represent the aggregate grant date fair value for option awards for fiscal years 2012 and 2011, respectively, computed in accordance with FASB ASC Topic 718. Please see Note 2 of the Notes to Consolidated Financial Statements contained in our 2012 Annual Report on Form 10-K for an explanation of the assumptions made in valuing these awards.
|
|
Employment Agreements
|
|
Name
|
Number of Securities Underlying Unexercised Options
(#) Exercisable
|
Number of Securities Underlying Unexercised Options
(#) Unexercisable
|
Option Exercise Price
($)
|
Option Expiration Date
|
Number of Shares or Units of Stock That Have Not Vested
(#)
|
Market Value of Shares or Units of Stock That Have Not Vested
($)
(1)
|
||||||||||||||||||
|
Joseph Laezza
(2)
|
12,500 | (5) | — | $ | 4.68 |
8/10/2015
|
— | — | ||||||||||||||||
| 25,000 | (6) | — | $ | 1.64 |
6/27/2016
|
— | — | |||||||||||||||||
| 62,500 | (5) | — | $ | 2.08 |
5/15/2017
|
— | — | |||||||||||||||||
| 45,000 | (6) | — | $ | 1.60 |
3/20/2019
|
— | — | |||||||||||||||||
| — | 25,000 | (5) | $ | 2.52 |
4/6/2020
|
— | — | |||||||||||||||||
| — | 250,000 | (5) | $ | 3.02 |
3/12/2022
|
— | — | |||||||||||||||||
| — | 250,000 | (5) | $ | 3.47 |
3/12/2022
|
— | — | |||||||||||||||||
| — | — | — | — | 67,500 | (8) | $ | 134,325 | |||||||||||||||||
| — | — | — | — | 37,500 | (8) | $ | 74,625 | |||||||||||||||||
| — | — | — | — | 4,166 | (8) | $ | 8,290 | |||||||||||||||||
| — | — | — | — | 12,500 | (5) | $ | 24,875 | |||||||||||||||||
| — | — | — | — | 250,000 | (5) | $ | 497,500 | |||||||||||||||||
|
Steven Peri
|
— | 50,000 | (3) | $ | 3.02 |
9/04/2022
|
— | — | ||||||||||||||||
| — | 50,000 | (3) | $ | 3.47 |
9/04/2022
|
— | ||||||||||||||||||
| — | — | — | — | 150,000 | (3) | $ | 298,500 | |||||||||||||||||
|
Tolga Sakman
(4)
|
— | 37,500 | (7) | $ | 3.02 |
3/12/2022
|
— | — | ||||||||||||||||
| — | 37,500 | (7) | $ | 3.47 |
3/12/2022
|
— | ||||||||||||||||||
| — | — | — | — | 50,000 | (7) | $ | 99,500 | |||||||||||||||||
| — | — | — | — | 50,000 | (7) | $ | 99,500 | |||||||||||||||||
| — | — | — | — | 50,000 | (7) | $ | 99,500 | |||||||||||||||||
|
(1)
|
The market value of the stock awards is based on the $1.99 closing price of our common stock on December 31, 2012.
|
|
(2)
|
Mr. Laezza resigned from the Company on January 11, 2013.
|
|
(3)
|
These option and restricted stock awards were granted on September 4, 2012 and vest upon the earlier to occur of 10 years or the Company’s change in control (as defined in the Company’s 2007 Stock Incentive Plan).
|
|
(4)
|
Mr. Sakman resigned from the Company on March 22, 2013.
|
|
(5)
|
These option and restricted stock awards were forfeited on January 11, 2013 in accordance with Mr. Laezza’s severance agreement.
|
|
(6)
|
These option awards were exchanged for 13,500 shares of common stock on January 11, 2013 in accordance with Mr. Laezza’s severance agreement.
|
|
(7)
|
These option and restricted stock awards were forfeited on March 22, 2013 in accordance with Mr. Sakman’s severance agreement.
|
|
(8)
|
These restricted stock awards vested on January 11, 2013 in accordance with Mr. Laezza’s severance agreement.
|
|
Potential Payments upon Termination or Change-in-Control
|
|
Name
|
Fees
|
Option
Awards
(1)
|
Total
|
|||||||||
|
Kenneth Archer
|
$ | 32,234 | $ | 162,218 | $ | 194,452 | ||||||
|
Grant Dawson
|
33,841 | 162,218 | 196,059 | |||||||||
|
Jon DeLuca
|
13,669 | (2) | 162,218 | 175,887 | ||||||||
|
James S. Lusk
|
38,841 | 162,218 | 201,059 | |||||||||
|
(1)
|
These amounts represent the aggregate grant date fair value for option awards granted to each director in 2012 computed in accordance with FASB ASC Topic 718. Please See Note 2 of the Notes to Consolidated Financial Statements contained in our 2012 Annual Report on Form 10-K for an explanation of the assumptions made in valuing these awards.
|
|
(2)
|
Mr. DeLuca elected to receive his compensation in the form of restricted stock in accordance with the Director Policy.
|
|
Plan Category
|
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights
|
Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in the first column)
|
|||||||||
|
Equity compensation plans approved
by security holders
|
1,757,067 | $ | 3.07 | 321,118 | ||||||||
|
Respectfully submitted,
|
|
|
James S. Lusk,
Chairman
Kenneth Archer
Grant Dawson
|
|
●
|
Stockholders whose shares are registered in their own name should contact our transfer agent, American Stock Transfer & Trust Company, and inform them of their request by calling them at (800) 937-5449 or writing them at 59 Maiden Lane, Plaza Level, New York, New York 10038.
|
|
●
|
Stockholders whose shares are held by a broker or other nominee should contact such broker or other nominee directly and inform them of their request. Stockholders should be sure to include their name, the name of their brokerage firm and their account number.
|
|
PROXY VOTING INSTRUCTIONS
|
|
COMPANY NUMBER
|
|
|
ACCOUNT NUMBER
|
|
|
You may enter your voting instructions at 1-800-PROXIES up until 11:59 PM Eastern Time the day before the cut-off or meeting date.
|
|
For
|
Against
|
Abstain
|
||||
|
1.
|
To elect the following nominees to our Board of Directors to each serve until our next Annual Meeting of Stockholders, or until their respective successors are duly elected and qualified:
|
|||||
|
Vote for All
|
[ ] | [ ] | [ ] | |||
|
Withhold Authority for All Nominees
|
[ ] | [ ] | [ ] | |||
|
For All Except (See instructions below)
|
[ ] | [ ] | [ ] | |||
|
Kenneth Archer
|
[ ] | [ ] | [ ] | |||
|
Grant Dawson
|
[ ] | [ ] | [ ] | |||
|
Jon A. DeLuca
|
[ ] | [ ] | [ ] | |||
|
Peter Holst
|
[ ] | [ ] | [ ] | |||
|
James S. Lusk
|
[ ] | [ ] | [ ] | |||
|
For
|
Against
|
Abstain
|
||||
|
2.
|
Approve, on an advisory basis, the compensation paid to Glowpoint, Inc.’s Named Executive Officers.
|
[ ] | [ ] | [ ] | ||
|
Every Year
|
Every Two Years
|
Every Three Years
|
Abstain
|
|||
|
3.
|
Approve, on an advisory basis, the frequency of which to hold stockholder advisory votes on executive compensation paid to Glowpoint, Inc.’s Named Executive Officers.
|
[ ] | [ ] | [ ] | [ ] | |
|
For
|
Against
|
Abstain
|
||||
|
4.
|
Ratify the appointment of EisnerAmper LLP as our Registered Public Accounting Firm for fiscal year 2013.
|
[ ] | [ ] | [ ] |
|
INSTRUCTION: To withhold authority to vote for any individual nominee(s), mark “FOR ALL EXCEPT” and fill in the circle next to each nominee you wish to withhold
|
||
|
To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.
|
[ ] | |
|
Signature of Stockholder:
|
Date:
|
Signature of Stockholder:
|
Date:
|
|
Note:
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|